Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions

Journal of Psychiatric Research

Volumn 44, Issue 6, 2010, Pages 347-355

  Roger, Sébastien ^a   Mei, Zhu Zhong ^b,e   Baldwin, Jocelyn M ^b   Dong, Li ^b,c   Bradley, Helen ^b   Baldwin, Stephen A ^b   Surprenant, Annmarie ^d   Jiang, Lin Hua ^b  

^a UNIVERSITÉ DE TOURS   (France)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Affective mood disorder; P2X7 receptor; Receptor function; Single nucleotide polymorphism; Structural modelling

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; PURINERGIC P2X7 RECEPTOR;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR GENETICS; MOOD DISORDER; MUTANT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS;

ADENOSINE TRIPHOSPHATE; BLOTTING, WESTERN; CALCIUM CHANNELS; CELL LINE; ELECTROPHYSIOLOGY; HUMANS; KIDNEY; MUTAGENESIS, SITE-DIRECTED; MUTATION; PATCH-CLAMP TECHNIQUES; POLYMORPHISM, SINGLE NUCLEOTIDE; PORINS; RECEPTORS, PURINERGIC P2;

EID: 77950941000     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2009.10.005     Document Type: Article

References (83)

1. Alcaraz L., Baxter A., Bent J., Bowers K., Braddock M., Cladingboel D., et al. Novel P2X7 receptor antagonists. Bioorganic and Medicinal Chemistry Letters 2003, 13:4043-4046.
2. Anderson C.M., Nedergaard M. Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons 2006, 29:257-261.
3. Barden N., Harvey M., Gagne B., Shink E., Tremblay M., Raymond C., et al. Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. American Journal of Medical Genetics B Neuropsychiatry Genetics 2006, 141B:374-382.
4. Bianco F., Ceruti S., Colombo A., Fumagalli M., Ferrari D., Pizzirani C., et al. A role for P2X7 in microglial proliferation. Journal of Neurochemistry 2006, 99:745-758.
5. Boldt W., Klapperstuck M., Buttner C., Sadtler S., Schmalzing G., Markwardt F. Glu496Ala polymorphism of human P2X7 receptor does not affect its electrophysiological phenotype. American Journal of Physiology Cell Physiology 2003, 284:C749-C756.
6. Burnstock G. Purinergic signalling and disorders of the central nervous system. Nature Reviews Drug Discovery 2008, 7:575-590.
7. Blazer D.G., Kessler R.C., McGonagle K.A., Swartz M.S. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. American Journal of Psychiatry 1994, 151:979-986.
8. Bodin P., Burnstock G. Purinergic signalling: ATP release. Neurochemical Research 2001, 26:959-969.
9. Cabrini G., Falzoni S., Forchap S.L., Pellegatti P., Balboni A., Agostini P., et al. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. Journal of Immunology 2005, 175:82-89.
10. Chen Y., Zhang X., Wang C., Li G., Gu Y., Huang L.Y. Activation of P2X7 receptors in glial satellite cells reduces pain through downregulation of P2X3 receptors in nociceptive neurons. Proceedings of National Academy of Sciences United States of America 2008, 105:16773-16778.
11. Chessell I.P., Simon J., Hibell A.D., Michel A.D., Barnard E.A., Humphrey P.P.A. Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Letters 1998, 439:26-30.
12. Chessell I.P., Hatcher J.P., Bountra C., Michel A.D., Hughes J.P., Green P., et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005, 114:386-396.
13. Choi H.B., Ryu J.K., Kim S.U., McLarnon J.G. Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain. Journal of Neuroscience 2007, 27:4957-4968.
14. Craddock N., Jones I. Genetics of bipolar disorder. Journal of Medical Genetics 1999, 36:585-594.
15. Dardano A., Falzoni S., Caraccio N., Polini A., Tognini S., Solini A., et al. 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters. Journal of Clinical Endocrinology and Metabolism 2009, 94:695-698.
16. Davis I.W., Leaver-Fay A., Chen V.B., Block J.N., Kapral G.J., Wang X., et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Research 2007, 35:W375-W383.
17. Denlinger L.C., Fisette P.L., Sommer J.A., Watters J.J., Prabhu U., Dubyak G.R., et al. Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. Journal of Immunology 2001, 167:1871-1876.
18. Denlinger L.C., Angelini G., Schell K., Green D.N., Guadarrama A.G., Prabhu U., et al. Detection of human P2X7 nucleotide receptor polymorphisms by a novel monocyte pore assay predictive of alterations in lipopolysaccharide-induced cytokine production. Journal of Immunology 2005, 174:4424-4431.
19. Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends in Pharmacology and Toxicology 2007, 28:465-472.
20. Duan S., Neary J.T. P2X(7) receptors: properties and relevance to CNS function. Glia 2006, 54:738-746.
21. Duan S., Anderson C.M., Keung E.C., Chen Y., Swanson R.A. P2X7 receptor-mediated release of excitatory amino acids from astrocytes. Journal of Neuroscience 2003, 23:1320-1328.
22. Erhardt A., Lucae S., Unschuld P.G., Ising M., Kern N., Salyakina D., et al. Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders. Journal of Affective Disorder 2007, 101:159-168.
23. Fernando S.L., Saunders B.M., Sluyter R., Skarratt K.K., Goldberg H., Marks G.B., et al. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine 2007, 175:360-366.
24. Fields R.D., Burnstock G. Purinergic signalling in neuron-glia interactions. Nature Reviews Neuroscience 2006, 7:423-436.
25. Fiser A., Sali A. ModLoop: automated modeling of loops in protein structures. Bioinformatics 2003, 19:2500-2501.
26. Fiser A., Sali A. Modeller: generation and refinement of homology-based protein structure models. Methods in Enzymology 2008, 374:461-491.
27. Grant B.F., Stinson F.S., Hasin D.S., Dawson D.A., Chou S.P., Ruan W.J., et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 2005, 66:1205-1215.
28. Green EK, Grozeva D, Raybould R, Elvidge G, Macgregor S, Craig I, et al., P2RX7: a bipolar and unipolar disorder candidate susceptibility gene? American Journal of Medical Genetics B Neuropsychiatry Genetics, 2009 [epub].
29. Grigoroiu-Serbanescu M, Herms S, Mühleisen TW, Georgi A, Diaconu CC, Strohmaier J, et al. Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samples. American Journal of Medical Genetics B Neuropsychiatry Genetics, 2009 [epub].
30. Gu B.J., Zhang W., Worthington R.A., Sluyter R., Dao-Ung P., Petrou S., et al. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. Journal of Biological Chemistry 2001, 276:11135-11142.
31. Hejjas K., Szekely A., Domotor E., Halmai Z., Balogh G., Schilling B., et al. Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach. American Journal of Medical Genetics B Neuropsychiatry Genetics 2009, 150B:295-299.
32. Honore P., Donnelly-Roberts D., Namovic M.T., Hsieh G., Zhu C.Z., Mikusa J.P., et al. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. Journal of Pharmacology and Experimental Therapy 2006, 319:1376-1385.
33. Jacobi F., Wittchen H.U., Holting C., Hofler M., Pfister H., Muller N., et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychological Medicine 2004, 34:597-611.
34. Kawate T., Michel J.C., Birdsong W.T., Gouaux E. Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 2009, 460:592-598.
35. Kelsoe J.R. Arguments for the genetic basis of the bipolar spectrum. Journal of Affective Disorder 2003, 73:183-197.
36. Kendler K.S., Prescott C.A. A population-based twin study of lifetime major depression in men and women. Archives of General Psychiatry 1999, 56:39-44.
37. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
38. Khakh B.S., North R.A. P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006, 442:527-532.
39. Kieseppa T., Partonen T., Haukka J., Kaprio J., Lonnqvist J. High concordance of bipolar I disorder in a nationwide sample of twins. American Journal of Psychiatry 2004, 161:1814-1821.
40. Kim M., Jiang L.H., Wilson H.L., North R.A., Surprenant A. Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO Journal 2001, 20:6347-6358.
41. Jiang L.H., Rassendren F., Mackenzie A., Zhang Y.H., Surprenant A., North N.A. N-methyl-d-glucamine and propidium dyes utilize different permeation pathways at rat P2X(7) receptors. American Journal of Physiology Cell Physiology 2005, 289:C1295-C1302.
42. Liu H.C., Yang Y.Y., Chou Y.M., Chen K.P., Shen W.W., Leu S.J. Immunologic variables in acute mania of bipolar disorder. Journal of Neuroimmunology 2004, 150:116-122.
43. Liu X., Surprenant A., Mao H.J., Roger S., Xia R., Bradley H., et al. Identification of key residues coordinating functional inhibition of P2X7 receptors by zinc and copper. Molecular Pharmacology 2008, 73:252-259.
44. Liu X., Ma W., Surprenant A., Jiang L.H. Identification of the amino acid residues in the extracellular domain of rat P2X(7) receptor involved in functional inhibition by acidic pH. British Journal of Pharmacology 2009, 156:135-142.
45. Lucae S., Salyakina D., Barden N., Harvey M., Gagne B., Labbe M., et al. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Human Molecular Genetics 2006, 15:2438-2445.
46. McGaraughty S., Chu K.L., Namovic M.T., Donnelly-Roberts D.L., Harris R.R., Zhang X.F., et al. P2X7-related modulation of pathological nociception in rats. Neuroscience 2007, 146:1817-1828.
47. McGuffin P., Katz R., Watkins S., Rutherford J. A hospital-based twin register of the heritability of DSM-IV unipolar depression. Archives of General Psychiatry 1996, 53:129-136.
48. McLarnon J.G., Ryu J.K., Walker D.G., Choi H.B. Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus. Journal of Neuropathology and Experimental Neurology 2006, 65:1090-1097.
49. McQuillin A., Bass N.J., Choudhury K., Puri V., Kosmin M., Lawrence J., et al. Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders. Molecular Psychiatry 2009, 14:614-620.
50. Mei Z.Z., Mao H.J., Jiang L.H. Conserved cysteine residues in the pore region are obligatory for human TRPM2 channel function. American Journal of Physiology Cell Physiology 2006, 291:C1022-C1028.
51. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 2009, 65:732-741.
52. Mitterauer B. Imbalance of glial-neuronal interaction in synapses: a possible mechanism of the pathophysiology of bipolar disorder. Neuroscientist 2004, 10:199-206.
53. Morissette J., Villeneuve A., Bordeleau L., Rochette D., Laberge C., Gagne B., et al. Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24. American Journal of Medical Genetics 1999, 88:567-587.
54. Monif M., Reid C.A., Powell K.L., Smart M.L., Williams D.A. The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. Journal of Neuroscience 2009, 29:3781-3791.
55. Nelson D.W., Gregg R.J., Kort M.E., Perez-Medrano A., Voight E.A., Wang Y., et al. Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists. Journal of Medicinal Chemistry 2006, 49:3659-3666.
56. North R.A. Molecular physiology of P2X receptors. Physiological Review 2002, 82:1013-1067.
57. Ownby R.L., Crocco E., Acevedo A., John V., Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Archives of General Psychiatry 2006, 63:530-538.
58. Parvathenani L.K., Tertyshnikova S., Greco C.R., Roberts S.B., Robertson B., Posmantur R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. Journal of Biological Chemistry 2003, 278:13309-13317.
59. Pelegrin P., Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO Journal 2006, 25:5071-5082.
60. Rapp M.A., Schnaider-Beeri M., Grossman H.T., Sano M., Perl D.P., Purohit D.P., et al. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Archives of General Psychiatry 2006, 63:161-167.
61. Rapp M.A., Schnaider-Beeri M., Purohit D.P., Perl D.P., Haroutunian V., Sano M. Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. American Journal of Geriatric Psychiatry 2008, 16:168-174.
62. Rassendren F., Buell G.N., Virginio C., Collo G., North R.A., Surprenant A. The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. Journal of Biological Chemistry 1997, 272:5482-5486.
63. Roger S., Pelegrin P., Surprenant A. Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding. Journal of Neuroscience 2008, 28:6393-6401.
64. Romagnoli R., Baraldi P.G., Cruz-Lopez O., Lopez-Cara C., Preti D., Borea P.A., et al. The P2X7 receptor as a therapeutic target. Expert Opinion on Therapeutic Targets 2008, 12:647-661.
65. Sanz J.M., Chiozzim P., Ferrari D., Colaianna M., Idzko M., Falzoni S., Fellin R., et al. Activation of microglia by amyloid {beta} requires P2X7 receptor expression. Journal of Immunology 2009, 182:4378-4485.
66. Saunders B.M., Fernando S.L., Sluyter R., Britton W.J., Wiley J.S. A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. Journal of Immunology 2003, 171:5442-5446.
67. Shemon A.N., Sluyter R., Fernando S.L., Clarke A.L., Dao-Ung L.P., Skarratt K.K., et al. A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. Journal of Biological Chemistry 2006, 281:2079-2086.
68. Sluyter R., Dalitz J.G., Wiley J.S. P2X7 receptor polymorphism impairs extracellular adenosine 5'-triphosphate-induced interleukin-18 release from human monocytes. Genes & Immunity 2004, 5:588-591.
69. Solle M., Labasi J., Perregaux D.G., Stam E., Petrushova N., Koller B.H., et al. Altered cytokine production in mice lacking P2X(7) receptors. Journal of Biological Chemistry 2001, 276:125-132.
70. Somers J.M., Goldner E.M., Waraich P., Hsu L. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Canadian Journal of Psychiatry 2006, 51:100-113.
71. Shink E., Harvey M., Tremblay M., Gagne B., Belleau P., Raymond C., et al. Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region. American Journal of Medical Genetics B Neuropsychiatry Genetics 2005, 135B:50-58.
72. Sim J.A., Young M.T., Sung H.Y., North R.A., Surprenant A. Reanalysis of P2X7 receptor expression in rodent brain. Journal of Neuroscience 2004, 24:6307-6314.
73. Stokes L., Jiang L.H., Alcaraz L., Bent J., Bowers K., et al. Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373. British Journal of Pharmacology 2006, 149:880-887.
74. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. American Journal of Psychiatry 2000, 157:1552-1562.
75. Surprenant A., Rassendren F., Kawashima E., North R.A., Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996, 272:735-738.
76. Surprenant A., North R.A. Signaling at Purinergic P2X Receptors. Annual Review of Physiology 2009, 71:333-359.
77. Thunberg U., Tobin G., Johnson A., Soderberg O., Padyukov L., Hultdin M., et al. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet 2002, 360:1935-1939.
78. Tonelli L.H., Postolache T.T., Sternberg E.M. Inflammatory genes and neural activity: involvement of immune genes in synaptic function and behavior. Frontiers in Bioscience 2005, 10:675-680.
79. Virginio C., Church D., North R.A., Surprenant A. Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology 1997, 36:1285-1294.
80. Wiley J.S., Dao-Ung L.P., Gu B.J., Sluyter R., Shemon A.N., Li C., et al. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 2002, 359:1114-1119.
81. Wiley J.S., Dao-Ung L.P., Li C., Shemon A.N., Gu B.J., et al. An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. Journal of Biological Chemistry 2003, 278:17108-17113.
82. Wilkinson W.J., Jiang L.H., Surprenant A., North R.A. Role of ectodomain lysines in the subunits of the heteromeric P2X2/3 receptor. Molecular Pharmacology 2006, 70:1159-1163.
83. Wilson H.L., Wilson S.A., Surprenant A., North R.A. Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. Journal of Biological Chemistry 2002, 277:34017-34023.